Functional psychopharmacology is the way to go in pharmacotherapy for psychiatric disorders

Acta Psychiatrica Scandinavica

Volumn 122, Issue 6, 2010, Pages 435-437

  Loonen, Anton J M ^a   Stahl, Stephen M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; MONOAMINE OXIDASE INHIBITOR; PSYCHOTROPIC AGENT; SEROTONIN 2A ANTAGONIST;

CLINICAL PRACTICE; CLINICAL RESEARCH; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE CLASSIFICATION; DRUG LEGISLATION; DRUG RECEPTOR BINDING; EDITORIAL; EVIDENCE BASED MEDICINE; HUMAN; MALPRACTICE; MENTAL DISEASE; PERSONALITY DISORDER; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; SCHIZOPHRENIA;

EVIDENCE-BASED MEDICINE; HUMANS; MENTAL DISORDERS; PSYCHOPHARMACOLOGY; PSYCHOTROPIC DRUGS;

EID: 78149386499     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2010.01628.x     Document Type: Editorial

References (6)

1. Sacket DL, Rosenberg WMC, Gray JAM, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. BMJ 1996;312:71-72.
2. Task force. Diagnostic and statistical manual of mental disorders, 3rd edn. Washington DC: American Psychiatric Association, 1980.
3. Landelijke Stuurgroep Multidisciplinaire Richtlijnontwikkeling in de GGZ Multidisciplinaire richtlijn persoonlijkheidsstoornissen. Utrecht: Trimbos-instituut, 2008.
4. Van Praag HM. Past expectations, present disappointments, future hopes or psychopathology as the rate-limiting step of progress in psychopharmacology. Hum Psychopharmacol 2001;16:3-7.
5. Stahl SM. Stahl's essential psychopharmacology, 3rd edn. New York: Cambridge University Press, 2008:639-650.
6. Ghaemi SN. The case for, and against, evidence-based psychiatry. Acta Psychiatr Scand 2009;119:249-251.